<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Relations between clinical course and change in aldolase (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALD</z:e>) isoenzyme pattern were investigated on the peripheral and bone marrow blood of <z:mpath ids='MPATH_458'>normal</z:mpath> subjects and patients suffering from <z:hpo ids='HP_0001909'>leukemia</z:hpo>, <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo>, <z:hpo ids='HP_0001908'>hypoplastic anemia</z:hpo> and other <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disorders</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Similar examination was performed on human <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells and on sera and leukocytes from Donryu rats inoculated with rat <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells (DBLA-6), induced by NBU </plain></SENT>
<SENT sid="2" pm="."><plain>In addition to the enzyme activity, isoenzyme pattern was analyzed electrophoretically </plain></SENT>
<SENT sid="3" pm="."><plain>The results obtained were as follows: 1) FDP/F1P ratios of the peripheral and marrow blood were high in untreated <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>After the induction therapy, the ratio in the marrow blood was high, but decreased in peripheral blood </plain></SENT>
<SENT sid="5" pm="."><plain>2) In complete remission, both ratios were decreased to <z:mpath ids='MPATH_458'>normal</z:mpath> level </plain></SENT>
<SENT sid="6" pm="."><plain>3) In the early relapse of <z:hpo ids='HP_0001909'>leukemia</z:hpo>, the marrow blood showed a high ratio in spite of <z:mpath ids='MPATH_458'>normal</z:mpath> value in the peripheral blood </plain></SENT>
<SENT sid="7" pm="."><plain>During full relapse or reinduction therapy, FDP/F1P ratio remained high in both the peripheral and marrow blood </plain></SENT>
<SENT sid="8" pm="."><plain>4) Atypical hypoplastic <z:hpo ids='HP_0001909'>leukemia</z:hpo> showed a significantly high ratio in the marrow, but a low ratio in the periphery </plain></SENT>
<SENT sid="9" pm="."><plain>No difference in either ratio was detected between <z:hpo ids='HP_0001908'>hypoplastic anemia</z:hpo> and <z:mpath ids='MPATH_458'>normal</z:mpath> subjects </plain></SENT>
<SENT sid="10" pm="."><plain>5) Zymogram of <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells from <z:hpo ids='HP_0001909'>leukemia</z:hpo> patients showed that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALD</z:e>-A was predominant more clearly than in <z:mpath ids='MPATH_458'>normal</z:mpath> leukocytes </plain></SENT>
<SENT sid="11" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALD</z:e> in <z:mpath ids='MPATH_458'>normal</z:mpath> leukocytes was composed mainly of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALD</z:e>-A and its hybrids with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALD</z:e>-B and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALD</z:e>-C </plain></SENT>
<SENT sid="12" pm="."><plain>6) The ratio in sera and leukocytes from rats inoculated with DBLA-6 cells was increased with exacerbation of <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="13" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALD</z:e>-A was predominant in rat <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells on the zymogram </plain></SENT>
<SENT sid="14" pm="."><plain>It is concluded that aldolase isoenzymes, especially the FDP/F1P ratio, are useful in estimating clinical course of <z:hpo ids='HP_0001909'>leukemia</z:hpo>, particularly in deciding early relapse of <z:hpo ids='HP_0001909'>leukemia</z:hpo> in bone marrow </plain></SENT>
<SENT sid="15" pm="."><plain>These laboratory findings are also useful in differentiating atypical <z:hpo ids='HP_0001909'>leukemia</z:hpo> from <z:hpo ids='HP_0001908'>hypoplastic anemia</z:hpo> </plain></SENT>
</text></document>